Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 9,638%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 9,638.02% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 1,777.93% |
Abivax SA American Depositary Shares (ABVX) | 1,432.18% |
Cidara Therapeutics (CDTX) | 715.12% |
Celcuity LLC (CELC) | 656.43% |
TMC the metals (TMC) | 577.19% |
GRAIL, LLC (GRAL) | 467.85% |
Sandisk (SNDK) | 454.42% |
Cogent Biosciences (COGT) | 395.7% |
Terns Pharmaceuticals (TERN) | 387.41% |
Olema Pharmaceuticals (OLMA) | 360.3% |
Opendoor Technologies (OPEN) | 327.08% |
Centrus Energy (LEU) | 297.07% |
Aris Mining (ARMN) | 294.37% |
Metsera, Inc Common Stock (MTSR) | 291.67% |
ViaSat (VSAT) | 289.66% |
Cipher Mining (CIFR) | 284.92% |
Applied Digital (APLD) | 274.01% |
Aura Minerals Inc Common Shares (AUGO) | 269.63% |
Sibanye Gold Ltd ADR (SBSW) | 265.69% |
CommScope (COMM) | 261.6% |
Ondas (ONDS) | 256.8% |
Arrowhead Pharmaceuticals (ARWR) | 243.59% |
DRDGOLD Limited ADR (DRD) | 230.49% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
